Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes.
Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes.
PLoS One. 2013; 8(2):
Coll RC, O’Neill LA
[This corrects the article on p. e29539 in vol. 6.]. HubMed – drug